AFREZZA® (insulin human) Inhalation Powder: A Review in Diabetes Mellitus

Drugs11.50
Volume: 75, Issue: 14, Pages: 1679 - 1686
Published: Sep 1, 2015
Abstract
Afrezza® (insulin human) inhalation powder is a rapid-acting Technosphere® insulin (TI) administered via a breath-powered oral inhaler to patients with diabetes requiring prandial insulin. TI, a dry powdered formulation of recombinant human insulin adsorbed onto a proprietary carrier, is designed to deliver insulin to the deep lung, at the level of the alveoli, where it is absorbed into the systemic circulation. In a randomized, open-label,...
Paper Details
Title
AFREZZA® (insulin human) Inhalation Powder: A Review in Diabetes Mellitus
Published Date
Sep 1, 2015
Journal
Volume
75
Issue
14
Pages
1679 - 1686
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.